Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2010
08/31/2010CA2447779C Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
08/26/2010WO2010096426A2 Compounds, compositions, methods of synthesis, and methods of treatment
08/26/2010WO2010096384A2 Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands
08/26/2010WO2010096170A2 Inhibition of trna synthetases and therapeutic applications thereof
08/26/2010WO2010096115A1 Compounds, compositions and methods for control of hepatitis c viral infections
08/26/2010WO2010095849A2 Acid addition salt of udenafil, preparation method thereof and phamaceutical composition comprising the same
08/26/2010WO2010095765A1 Ring compound
08/26/2010WO2010095663A1 Fused heterocyclic ring compound
08/26/2010WO2010095390A1 Photosensitive resin composition
08/26/2010WO2010094955A1 Pyrimidopyridazine derivatives useful as p38 mapk inhibitors
08/26/2010WO2010094669A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives
08/26/2010WO2010094126A1 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/26/2010US20100216988 Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
08/26/2010US20100216970 Methods, compositions, and apparatuses for forming macrocyclic compounds
08/26/2010US20100216809 Piperidine/piperazine derivatives
08/26/2010US20100216808 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
08/26/2010US20100216799 Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists
08/26/2010US20100216798 Fused heterocycles as lck inhibitors
08/26/2010US20100216788 Fused heterocyclic compound
08/26/2010US20100216781 mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
08/26/2010US20100216769 Substituted glycinamides, process for their manufacture and use thereof as medicaments
08/26/2010US20100216768 N-substituted azaindoles and methods of use
08/26/2010US20100216765 Kinase inhibitors
08/26/2010US20100216764 Soluble Guanylate Cyclase Activators
08/26/2010CA2752756A1 Pyrimidopyridazine derivatives useful as p38 mapk inhibitors
08/26/2010CA2751639A1 Acid addition salt of udenafil, preparation method thereof and phamaceutical composition comprising the same
08/26/2010CA2750635A1 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/26/2010CA2749649A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives
08/25/2010EP2221308A1 Benzazepinone compound
08/25/2010EP2221299A2 Preparation of cilazapril intermediates
08/25/2010EP2220093A2 Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
08/25/2010EP2220092A1 Azaindolizines and methods of use
08/25/2010EP2220091A2 Reverse transcriptase inhibitors
08/25/2010EP2220089A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
08/25/2010EP2220088A2 New smac mimetic compounds as apoptosis inducers
08/25/2010EP1931641B1 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI
08/25/2010EP1637531B1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
08/25/2010EP1551834B1 Substituted quinazolinone compounds
08/25/2010EP1517892B1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
08/25/2010EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors
08/25/2010CN101815717A Metabolites of the JANUS kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-lh-pyrazol-l-yl)-3- cyclopentylpropanenitrile
08/25/2010CN101815712A Pyrazole compounds and their use as RAF inhibitors
08/25/2010CN101812097A Indole carbazole and bisindole maleimide alkaloid, preparation method and application thereof
08/25/2010CN101812064A Method for preparing acetamido metal naphthalene phthalocyanine
08/25/2010CN101812063A Alpha-naphthalenesulfonamide base quintuple heterocyclic compound and anti-tumor activity thereof
08/25/2010CN101812023A Novel method for preparing nitroorotic acid
08/24/2010US7781587 antitumor; breast cancer; 8,9-Dimethoxy-2,3-methylenedioxy-5-[2-(N,N-dimethylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one
08/24/2010US7781583 Synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-d] pryimidin-7-ones
08/24/2010US7781582 Process for the preparation of 2-amino-[1,2,4]triazolo[1,5-a]pyrimidines
08/24/2010US7781581 halogenating 2,4-diaminopyrimidine; cyclocondensation with potassium ethyl xanthogenate; intermediate in the preparation of certain thiazolo[4,5-d]pyrimidine nucleosides, which can have utility as immunomodulators
08/24/2010US7781440 Neurodegenerative diseases caused by GSK3 such as Alzheimer's disease
08/24/2010US7781439 such as 5-Chloro-6-(2,4-dichlorophenyl)-7-isopropylaminopyrazolo[1,5-a]pyrimidine-3-carboxylic acid, and optionally fungicides, bactericides, acaricides, nematocides and insecticides, used for controlling unwanted microorganisms
08/24/2010US7781436 such as 1-Benzyl-2-methyl-1H-indol-3-yl)-(4-phenyl-piperidin-1-yl)-methanone, vasopressin (V1a) receptor antagonists, for the treatment of dysmenorrhea, hypertension, congestive heart failure, inappropriate secretion of vasopressin, cirrhosis, nephrosis, obsessive compulsive disorder and as anxiolytics
08/24/2010CA2570028C Photoconductive members
08/24/2010CA2467538C New amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride) and processes to produce the same
08/24/2010CA2329320C Chlorin and bacteriochlorin-based aminophenyl dtpa and n2s2 conjugates for mr contrast media and radiopharmaceuticals
08/19/2010WO2010093425A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/19/2010WO2010093359A1 Compounds for the treatment of hepatitis c
08/19/2010WO2010093191A2 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
08/19/2010WO2010093128A2 Amphiphilic porphyrin derivatives and method for preparing the same
08/19/2010WO2010092371A1 Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer
08/19/2010WO2010092340A1 Fused pyridine and pyrazine derivatives as kinase inhibitors
08/19/2010WO2010092287A1 N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
08/19/2010WO2010092286A1 N-[(2-azabicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
08/19/2010WO2010092111A2 Compounds for non-invasive measurement of aggregates of amyloid peptides
08/19/2010WO2010092090A2 Novel salts of sitagliptin
08/19/2010WO2010091824A1 Fused pyrimidines as akt inhibitors
08/19/2010WO2010091808A1 Fused pyrimidines
08/19/2010WO2010074607A3 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
08/19/2010WO2010056656A3 Preparation of crystalline palonosetron hydrochloride
08/19/2010WO2010054114A3 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
08/19/2010WO2010054113A3 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
08/19/2010WO2010045542A3 Fused ring heteroaryl kinase inhibitors
08/19/2010WO2010045276A3 Azabenzimidazolones
08/19/2010WO2010032264A3 Improved process for preparation of (2r)-4-oxo-4-[3- (trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin- 7(8h)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine & new impurities in preparation thereof
08/19/2010US20100210839 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes
08/19/2010US20100210762 Heterocyclic compound, ultraviolet absorbent and composition containing the same
08/19/2010US20100210667 Imidazo [1, 2-c] pyrimidin-2-ylmethylpiperidines as orexin receptor antagonists
08/19/2010US20100210649 Pyridazinones and furan-containing compounds
08/19/2010US20100210642 Acetylenyl-pyrazolo-pyrimidine derivatives
08/19/2010US20100210639 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h 1,3,6,9 tetraaza-fluorenes as chk1 kinase function inhibitors
08/19/2010US20100210632 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
08/19/2010US20100210630 Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase
08/19/2010US20100210625 Novel1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands
08/19/2010US20100210622 Heterocyclic compounds and methods of use
08/19/2010US20100210620 Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers
08/19/2010US20100210474 Heterocyclic scaffolds useful for preparation of combinatorial libraries, libraries and methods for preparation thereof
08/19/2010US20100210451 Catalysts and methods for catalytic oxidation
08/19/2010US20100210036 Ppar active compounds
08/19/2010US20100209345 Fluorinated Ligands for Targeting Peripheral Benzodiazepine Receptors
08/19/2010US20100207114 Use of halogenated phthalocyanines
08/19/2010US20100206382 Photoelectric conversion devices
08/19/2010DE102009009277A1 Organische elektronische Vorrichtung The organic electronic device
08/19/2010CA2752114A1 Fused pyrimidines as akt inhibitors
08/19/2010CA2752073A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/19/2010CA2751866A1 N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
08/19/2010CA2751863A1 N-[(2-azabicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
08/19/2010CA2751385A1 Novel salts of sitagliptin
08/19/2010CA2749926A1 Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer
08/18/2010EP2218721A1 Novel salts of sitagliptin
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 573